1999
DOI: 10.1128/iai.67.8.4231-4236.1999
|View full text |Cite
|
Sign up to set email alerts
|

Interleukin-1 and Tumor Necrosis Factor Activities Partially Account for Calvarial Bone Resorption Induced by Local Injection of Lipopolysaccharide

Abstract: The present study was undertaken to test the hypothesis that tumor necrosis factor (TNF) and/or interleukin-1 (IL-1) activity mediates lipopolysaccharide (LPS)-induced bone resorption in vivo. To test this hypothesis, Escherichia coli LPS or Porphyromonas gingivalis LPS was injected into the subcutaneous tissues overlying mouse calvariae. Histological sections, prepared from the center of the lesion, were stained for tartrate-resistant acid phosphatase, and histomorphometric analysis was performed to quantify … Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1

Citation Types

4
97
0
2

Year Published

2002
2002
2019
2019

Publication Types

Select...
9
1

Relationship

1
9

Authors

Journals

citations
Cited by 168 publications
(103 citation statements)
references
References 47 publications
(42 reference statements)
4
97
0
2
Order By: Relevance
“…These findings were correlated with data demonstrating that P. gingivalis LPS induces bone resorption via the CD14 receptor since murine antibodies directed against the LPS receptor blocking the osteolytic properties of LPS (25). Study showed that bone resorption induced by P. gingivalis LPS is accounted for by an increase in the number of osteoclasts and the area of bone resorption in IL-1 receptor and TNF receptor-deficient mice (38). Taken together, the data suggest that the effect of P. gingivalis LPS on bone resorption is mainly enhanced by osteoclatogenesis via the CD14 receptor.…”
Section: Discussionsupporting
confidence: 79%
“…These findings were correlated with data demonstrating that P. gingivalis LPS induces bone resorption via the CD14 receptor since murine antibodies directed against the LPS receptor blocking the osteolytic properties of LPS (25). Study showed that bone resorption induced by P. gingivalis LPS is accounted for by an increase in the number of osteoclasts and the area of bone resorption in IL-1 receptor and TNF receptor-deficient mice (38). Taken together, the data suggest that the effect of P. gingivalis LPS on bone resorption is mainly enhanced by osteoclatogenesis via the CD14 receptor.…”
Section: Discussionsupporting
confidence: 79%
“…Synergistic stimulation of osteoclast differentiation by these cytokines may have important implications for a number of physiological and/or pathological conditions. Multiple cytokines appear to be involved in normal bone remodeling (26,44,64) as well as in stimulation of bone resorption in many pathological conditions including estrogen deficiency (27,38), hyperparathyroidism/humoral hypercalcemia of malignancy (23,24,61), hyperthyroidism (46), tumorinduced osteolysis (2,7,12,58), rheumatoid arthritis (19), lipopolysaccharide-induced osteolysis (1,11), and orthopedic implant loosening (36). Our CIMC-4 cells provide a model of osteoclast differentiation that should be Fig.…”
Section: Discussionmentioning
confidence: 99%
“…The affinity of LPS to its pattern recognition receptors, such as the TLRs and CD14, enables discrimination between commensal and pathogenic species. The P. gingivalis LPS is a stimulator of proinflammatory responses and bone resorption, as demonstrated in experimental animal models (Chiang et al, 1999;Nishida et al, 2001). In vitro, it stimulates proinflammatory cytokine production of, for example, IL-1a, IL-1b, IL-6, IL-8, IL-18 and tumour necrosis factor (TNF)-a in monocytes (Zhou et al, 2005;Bostanci et al, 2007a, b;Hamedi et al, 2009).…”
Section: The Lps Of P Gingivalismentioning
confidence: 99%